
Pfizer Strikes Landmark Deal with China’s 3SBio for Cancer Drug
(MENAFN) Pfizer, one of the largest American pharmaceutical companies, has struck a landmark deal with Chinese biotech firm 3SBio, marking the biggest transaction in China's biotechnology sector to date. The agreement, finalized on Friday, paves the …